AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HAEMONETICS CORP Director's Dealing 2019

May 13, 2019

31565_dirs_2019-05-13_e47b035d-48ff-4fa8-bac3-682e4b1f809a.zip

Director's Dealing

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2019-03-30

Reporting Person: KROLL MARK W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-12-24	Common Stock	G	1142	—	Disposed	23606	Direct

Footnotes

F1: Shares transferred as a bona fide gift without any consideration.

F2: This number includes unvested restricted stock units previously reported.